Org. age Ohio . 711 - The Ohio State University

50
George TG, Johnsamuel J, Delfin DA, Yakovich A, Mukherjee M, Phelps MA, Dalton JT, Sackett DL, Kaiser M,
Brun R, Werbovetz KA. Antikinetoplastid antimitotic activity and metabolic stability of dinitroaniline
sulfonamides and benzamides. Bioorganic and Medicinal Chemistry. 2006 May 2; [Epub ahead of print]
Gao W, Johnston JS, Miller DD, and Dalton JT. Interspecies differences in pharmacokinetics and metabolism of
S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)-propionamide: the role of
N-acetyltransferase, Drug Metab. Dispos., 34:254-260, 2006.
Wu D, George TG, Hurh E, Werbovetz KA, Dalton JT. Pre-systemic metabolism prevents in vivo
antikinetoplastid activity of N1,N4-substituted 3,5-dinitro sulfanilamide, GB-II-150. Life Sciences. 2006 Mar 28;
[Epub ahead of print]
Yong C and Frank SG. Characterization of Supersaturated Lidocaine/Polyacrylate Pressure Sensitive Adhesive
Systems: Thermal Analysis and FT-IR, J. Pharm. Sci., 95, 701-713, 2006.
Kim J, Bronson CL, Hayton WL, Radmacher MD, Roopenian DC, Robinson JM, and Anderson CL. Albumin
turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces. Am. J. Physiol.
290:G352-G360, 2006.
Shkriabai N, Datta SA, Zhao Z, Hess S, Rein A, Kvaratskhelia M. HIV-1 Gag interactions with assembly
cofactors. Biochemistry 45:4077-83, 2006.
X G. Wu, R.F. Barth, W. Yang, R. J. Lee, W. Tjarks, M.V. Backer, and J.M. Backer, Nanoparticles and High
Molecular Weight Boron Delivery Agents. (2006) in Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor
and Francis/CRC Press, Chapter 6
J. Guan, X. Pan, L. J. Lee, R.J. Lee. Viral, Non-Viral, and Physical Methods for Gene Delivery (2006) in
Biopharmaceutical Drug Design and Development, Ed. S. Wu-Pong, Humana Press.
X.B. Zhao, N. Muthusamy, J.C. Byrd, R.J. Lee, Folate Receptor-Targeted Liposomes for Cancer Therapy (2006)
in Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor and Francis/CRC Press, Chapter 33
Zhang Z-Y, Ugwu S, Zhang A, Ahmad MU, Ahmad I, Chiu S, Lee RJ. A novel cationic cardiolipin analogue for
gene delivery, Pharmazie 1, 2006.
Chiu S-J, Marcucci G, Lee RJ. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate
receptor-targeted liposomes, Anticancer Res. 26:1049-1056, 2006
Chiu S-J, Liu S, Perrotti D, Marcucci G, and Lee RJ. Efficient delivery of a Bcl-2-specific antisense
oligodeoxyribonucleotide (G3139) via transferrin receptor targeted liposomes, J. Control. Release 112:199-207,
2006.
Wu J, Liu Q, Lee R.J. A Folate Receptor-Targeted Liposomal Formulation for Paclitaxel. Int. J. Pharm. 316:148-
153, 2006.
Liu J, Levine AL, Mattoon JS, Yamaguchi M, Lee RJ, Pan X, and Rolsol TJ. Nanoparticles as image enhancing
agents for ultrasonography. Phys. Med. Biol. 51:2179-2189, 2006.
Wu XG, Barth RF, Yang W, Lee RJ, Tjarks W, Backer MV, and Backer JM, Nanoparticles and High Molecular
Weight Boron Delivery Agents. in Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor and Francis/CRC
Press, Chapter 6, 2006
Zhao XB, Muthusamy N, Byrd JC, Lee RJ. Folate Receptor-Targeted Liposomes for Cancer Therapy in
Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor and Francis/CRC Press, Chapter 33, 2006.
Guan J, Pan X, Lee LJ, Lee RJ. Viral, Non-Viral, and Physical Methods for Gene Delivery in Biopharmaceutical
Drug Design and Development, Ed. S. Wu-Pong, Humana Press, 2006.
X G. Wu, R.F. Barth, W. Yang, R. J. Lee, W. Tjarks, M.V. Backer, and J.M. Backer, Nanoparticles and High
Molecular Weight Boron Delivery Agents. (2006) in Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor
and Francis/CRC Press, Chapter 6